ASHLEY YORK: Open Payments
NPI 1750797197 · HOOVER, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,695 in 47 payments from 16 companies in 2025. Trend: 2023 $5,153 · 2024 $3,745 · 2025 $1,695
Food & beverage: $949Speaker / faculty: $713Education: $34
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 2 | $713 |
| Amgen Inc. | 11 | $221 |
| JAZZ PHARMACEUTICALS INC. | 5 | $118 |
| AstraZeneca Pharmaceuticals LP | 6 | $117 |
| Grifols USA, LLC | 3 | $98 |
| Regeneron Healthcare Solutions, Inc. | 4 | $87 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $70 |
| GENZYME CORPORATION | 2 | $60 |
| Resmed Corp | 3 | $46 |
| Janssen Biotech, Inc. | 2 | $38 |
Products named: Veozah, TEZSPIRE, DUPIXENT, XYWAV, Prolastin-C Liquid, FASENRA, OFEV, AIRSENSE.
Industry payments across AL — which companies pay providers there.
